Form 144 LABCORP HOLDINGS INC. For: 27 February

LabCorp Holdings Inc. filed a Form 144 with the Securities and Exchange Commission on February 27, 2026, indicating its intention to sell restricted securities. The healthcare and diagnostics company's stock was trading slightly lower at $0.07 per share at the time of the filing. Form 144 filings are not sales commitments but rather notifications of an intent to sell restricted securities that were acquired through private placements or other non-public offerings. These securities typically come with restrictions on resale, and once those restrictions expire, Form 144 must be filed at least one business day before any planned sale. LabCorp, a major player in laboratory services and drug development, has been navigating the evolving healthcare landscape, including increased competition and changing reimbursement policies. The filing comes amid a period of significant activity in the healthcare sector, with companies like LabCorp facing both opportunities and challenges. The broader market has seen notable movements in various sectors, with OpenAI reaching a $730 billion valuation following substantial investments from tech giants Amazon, NVIDIA, and SoftBank totaling $110 billion. Meanwhile, gold prices have been trending higher, with analysts at Bernstein providing updated forecasts for precious metals as the decade progresses. In the entertainment industry, Netflix made headlines by declining to match the Paramount/Skydance bid for Warner Bros, potentially reshaping the streaming landscape.